Voluntary Recall of Repackaged Avastin
A Georgia-based compounding pharmacy, Clinical Specialties, has issued a voluntary recall of repackaged Avastin due to potential problems associated with ophthalmic infections in some patients.
Click here for a complete list of the recalled preparations.
ABC News Story Quotes IACP
There is an ABC News story today - March 20, 2013, Two More Compounding Pharmacies Recall Drugs Over Infection Fears - regarding the two voluntary recalls in progress.
IACP is quoted at the beginning of the article. "We don't believe that there is data that points to an increase in these types of issues with compounded medications," the International Academy of Compounding Pharmacists, which represents 2,700 compounding pharmacists worldwide, said in a statement to ABCNews.com. "There is, however, increased vigilance on the part of all health care professionals, including physicians, nurses and pharmacists, and that increased vigilance is a good thing."
Also quoted in this ABC News story is Dr. Penny Asbell, an ophthalmologist who directs the Cornea Service and Refractive Surgery Center at the Mount Sinai Hospital in New York, "Health care professionals should be aware that repackaging sterile drugs without proper aseptic technique can compromise product sterility, potentially putting the patient at risk for microbial infections."
Still, Asbell said she believed compounding pharmacists were essential to the medical community because they allowed patients to get tailormade drugs that might never receive FDA-approval because they're needed by so few people. "I wouldn't knock any compounding pharmacist," she said. "Those serious about their business, serious about what they do, maintain sterile techniques and reliable methods for special uses that may never be FDA-approved."
Click here to read today's ABC News story.